DALLAS, TX--(Marketwire - May 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced the Company has signed a non-binding letter of intent (LOI) with Guardian Health Systems. The terms of the LOI include digiMedical reselling its proprietary Microsoft-based digiRX and digiReauth services in Guardian's existing markets and driving prescription traffic to Guardian's local, company-owned pharmacies. In return, digiMedical will receive a portion of sales from prescriptions that are fulfilled in Guardian pharmacies located throughout Oklahoma and Texas. Additionally, digiMedical will market Guardian's services to its existing network of physicians in the Dallas, Texas, Naples, Florida and Ft. Myers, Florida markets. The Companies also plan to partner as digiMedical explores the prescription compounding market with an emphasis on the growing veterinary sector. Prescription compounding services, which Guardian currently offers, provide more options to physicians for custom prescriptions that are not commercially available.

Guardian President and Founder, Jack Munn, stated, "Our partnership with digiMedical has the potential to be extremely beneficial for both companies. After twenty-one years in business we have developed a deep network of retail pharmacies and partners, in addition to our own Company-owned pharmacies that will benefit from digiMedical's proprietary prescription software. We also look forward to working with digiMedical to market our services as both companies focus on expanding their regional sales. Guardian is excited about the possibility of partnering with digiMedical to deliver digital prescription technologies to our well-established network of veterinarians throughout Texas and Oklahoma, a service that is not currently available in the industry but definitely needed."

digiMedical Prescription Handling Software and Pharmacies

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting and the Company owns and operates five pharmacies throughout Texas and Florida.

Company Fact Sheet and Updates

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to receive a Fact Sheet on the company, please send an e-mail to ir@digimedical.com.

About Guardian Health Systems

Guardian Health Systems is a 21year old, Texas-based health services company. The Company's main line of business is intravenous therapy, manufacturing sterile products used for intravenous pain management and antibiotics used to treat a range of infections, including MRSA. The Company compounds medications for both humans and animals delivering both custom and commercially available products. Guardian has its own Company-owned pharmacies in addition to a strong network of partner pharmacies throughout Texas and Oklahoma. The Company's mail order center services direct clients as well as delivering prescription fulfillment services for third parties, including insurance companies.

About digiMedical Solutions, Inc. ™

digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions'™ unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029